Charity Impact Media

Home › Medical research

Dana-Farbermass General Brigham Cancer CARE

Boston, MA · EIN 04-3320640 · 501(c)(3) · Supporting organization (509(a)(3))
Latest filing: Form 990 for the fiscal year ending September 30, 2025 (tax year 2024) · View the filing · Correct or respond

Dana-Farbermass General Brigham Cancer CARE reported $171.3 million in revenue and $170.7 million in expenses for the fiscal year ending September 30, 2025. Of every $100 it spent, $99.67 went to program services, $0.33 to management and general costs and $0.00 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 99.3% of the total. The highest compensation it reported for one person was $2,679,650 (FORMER OFFICER). Revenue rose 80% between FY2021 and FY2025. Source: Form 990, FY2025.

Where $100 of spending went

The fiscal year ending September 30, 2025 · Form 990, Part IX, line 25 · total expenses $171M

For context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

The fiscal year ending September 30, 2025 · Form 990, Part VIII · total revenue $171M

The 990 scorecard · same measures for every charity, no grades

FY2025 filing. Median across 169 covered charities in this category, from their latest filings.
MeasureFY2025Median
Program services
Part IX 25(B) ÷ 25(A)
99.7%83.9%
Management & general
Part IX 25(C) ÷ 25(A)
0.3%12.4%
Fundraising
Part IX 25(D) ÷ 25(A)
0.0%0.1%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
Not reported$0.01
Contributions & grants share of revenue
Part VIII 1h ÷ 12
0.0%72.7%
Government grants share of revenue
Part VIII 1e ÷ 12
0.0%0.0%
Program service revenue share
Part VIII 2g ÷ 12
99.3%5.8%
Highest reported compensation
Part VII-A, columns D–F
$2,679,650$628,890
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
1.57%1.94%
People paid over $100,000
Part VII, line 2
018
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
0.113.3
Independent voting board members
Part VI 1a–1b
0 of 693.8%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

FY2025 · Form 990, Part III · the three largest programs by expense
$170M expenses · 100.0% of program spending · revenue $170M

Clinical trial studies and research related to investigating new medications and methods of treatment of cancer, with hope of finding a cure

Highest reported compensation

FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
FORMER OFFICER
Former, 0.0 hrs/week
$0$2,313,019$366,631$2,679,650
TRESURER
Officer, 1.0 hrs/week
$0$2,090,208$77,538$2,167,746
TRUSTEE
Director/trustee, 1.0 hrs/week
$0$1,831,925$282,658$2,114,583
TRUSTEE, AND PRESIDENT (END 9/25/25)
Director/trustee, officer, 2.0 hrs/week
$0$1,169,226$81,307$1,250,533
TRUSTEE
Director/trustee, 1.0 hrs/week
$0$954,301$73,901$1,028,202
TRUSTEE, AND PRESIDENT (AS OF 9/26/25)
Director/trustee, officer, 2.0 hrs/week
$0$752,787$92,059$844,846
TRUSTEE (AS OF 3/28/25, END 9/25/25)
Director/trustee, 1.0 hrs/week
$0$735,145$90,531$825,676
TRUSTEE
Director/trustee, 2.0 hrs/week
$0$541,326$60,005$601,331

0 people received more than $100,000 in reportable compensation from Dana-Farbermass General Brigham Cancer CARE (Part VII, line 2).

5 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
FilingRevenueExpensesProgramsNet assetsTop pay
FY2025 ⓘ$171M$171M99.7%$1.8M$2,679,650
FY2024 ⓘ$138M$137M99.6%$1.2M$2,459,825
FY2023 ⓘ$106M$107M99.5%$614K$2,339,457
FY2022 ⓘ$97M$98M99.8%$8.0M$3,994,058
FY2021 ⓘ$95M$96M99.7%$12M$2,026,618

Governance answers, as filed

FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b6 · 0 independent
  • Audited financial statements Part XII 2bYes
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aYes
  • Board given the 990 before filing Part VI 11aYes
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26No
  • Lobbying, or a 501(h) election in effect Part IV 4No
  • Over $15,000 of professional fundraising services Part IV 18No
  • Over $10,000 of activity outside the U.S. Part IV 14bNo
  • Employees Part I, line 50

Private foundation grants it received

5 private foundations reported grants to Dana-Farbermass General Brigham Cancer CARE totaling $8,534 on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.

Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.

Correct a figure or respond

Every number above is copied from Dana-Farbermass General Brigham Cancer CARE's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for Dana-Farbermass General Brigham Cancer CARE, you can publish a response that is linked from this page.

Questions people ask

How much of Dana-Farbermass General Brigham Cancer CARE's spending goes to programs?

In the fiscal year ending September 30, 2025, Dana-Farbermass General Brigham Cancer CARE reported that 99.7% of its $170.7 million in expenses went to program services, 0.3% to management and general and 0.0% to fundraising (Form 990, Part IX).

How much does Dana-Farbermass General Brigham Cancer CARE pay its top executive?

The largest total compensation Dana-Farbermass General Brigham Cancer CARE reported for one person in the fiscal year ending September 30, 2025 was $2,679,650, for the role of FORMER OFFICER (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does Dana-Farbermass General Brigham Cancer CARE get its money?

Of $171.3 million in revenue in the fiscal year ending September 30, 2025, 0.0% came from contributions and grants and 99.3% from program service revenue (Form 990, Part VIII).

Is Dana-Farbermass General Brigham Cancer CARE a registered charity?

The IRS lists EIN 04-3320640 as a 501(c)(3) organization (supporting organization (509(a)(3))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • FY2025: Form 990 for the fiscal year ending September 30, 2025, object 202612259349302036 · read the filing
  • FY2024: Form 990 for the fiscal year ending September 30, 2024, object 202502239349300620 · read the filing
  • FY2023: Form 990 for the fiscal year ending September 30, 2023, object 202412139349300741 · read the filing
  • FY2022: Form 990 for the fiscal year ending September 30, 2022, object 202312239349301776 · read the filing
  • FY2021: Form 990 for the fiscal year ending September 30, 2021, object 202242239349302114 · read the filing

All filings for EIN 04-3320640: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.